Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream
Skin Research and Technology · 2024
DOI: 10.1111/srt.13790 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Fan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research & Development Center, Mageline Biology Tech Co., Ltd, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Skin Aging, Fibroblasts, Skin Cream. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The delicate periorbital region is susceptible to skin dehydration, wrinkles, and loss of elasticity. Thus, targeted and effective anti‐aging interventions are necessary for the periorbital area.
Aim
To evaluate the efficacy and safety of a new anti‐aging eye cream formulated with the active complex (Yeast/rice fermentation filtrate, N ‐acetylneuraminic acid, palmityl tripeptide‐1, and palmitoyl tetrapeptide‐7).
Methods
The cell viability and expressions of key extracellular matrix (ECM) components of the active complex were evaluated using a human skin fibroblast model. In the 12‐week clinical trial, skin hydration, elasticity, facial photographs, and collagen density following eye cream application were assessed using Corneometer, Cutometer, VISIA, and ultrasound device, respectively. Dermatologists and participants evaluated clinical efficacy and safety at baseline, and after 4, 8, and 12 weeks.
Results
PCR and immunofluorescent analyses revealed that the active complex significantly stimulated fibroblast proliferation ( p < 0.05) and markedly promote the synthesis of collagen and elastin. Clinical findings exhibited a substantial enhancement in skin hydration (28.12%), elasticity (18.81%), and collagen production (54.99%) following 12 weeks of eye cream application. Dermatological evaluations and participants’ assessments reported a significant improvement in skin moisture, roughness, elasticity, as well as fine lines and wrinkles by week 8.
Conclusion
The new anti‐aging eye cream, enriched with the active complex, demonstrates comprehensive rejuvenating effects, effectively addressing aging concerns in the periorbital area, coupled with a high safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research & Development Center, Mageline Biology Tech Co., Ltd, Wuhan, Hubei, China.
- Shanghai Skinshield Clinical Testing and Technological Research Ltd., Shanghai, China.
- Department of Dermatology, Air Force Medical Center, PLA, Beijing, China.
- Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
ORCID-Profile: Fan Yang
Zitieren
APA
Yang, F., Zhang, X., Wang, H., Guo, M., Zhang, J., Feng, X., Yu, J., Yang, J., Zhu, J., & Wang, Y. (2024). Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream. Skin Research and Technology. https://doi.org/10.1111/srt.13790
Vancouver
Yang F, Zhang X, Wang H, Guo M, Zhang J, Feng X, et al. Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream. Skin Research and Technology. 2024. doi:10.1111/srt.13790
BibTeX
@article{Yang2024,
author = {Yang, Fan and Zhang, Xinyuan and Wang, Hua and Guo, Miao and Zhang, Jinlong and Feng, Xuejiao and Yu, Jiayi and Yang, Jiahui and Zhu, Jinjin and Wang, Yiyu},
title = {Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13790}
}
EUVIMED